+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review

  • ID: 5235716
  • SWOT Analysis
  • November 2021
  • 49 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abliva AB
  • Alimera Sciences Inc
  • Allegro Ophthalmics LLC
  • Astellas Pharma Inc
  • Genentech USA Inc
  • Genzyme Corp
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Stealth BioTherapeutics Corp (Stealth BioTherapeutics), formerly Stealth Peptides International Inc, a subsidiary of Morningside Venture Investments Ltd, is an early stage biotechnology company. It discovers, develops, and commercializes novel therapies for diseases and disorders associated with mitochondrial dysfunction. The company is investigating elamipretide, a peptide compound that penetrates into cell membranes, for the treatment of primary mitochondrial myopathy, barth syndrome, leber’s hereditary optic neuropathy, duchenne cardiomyopathy, and dry age-related macular degeneration. Stealth BioTherapeutics is also evaluating SBT-20 for the treatment of neurodegenerative diseases related to mitochondrial dysfunction; and SBT-272, a phase I candidate, for the treatment of rare neurodegenerative diseases. Stealth BioTherapeutics is headquartered in Grand Cayman, Cayman Islands.

Stealth BioTherapeutics Corp Key Recent Developments


Nov 11, 2021: Stealth BioTherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
Aug 05, 2021: Stealth BioTherapeutics reports second quarter 2021 financial results and recent business highlights
Jul 30, 2021: Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5
Jul 07, 2021: Stealth BioTherapeutics joins the rare disease company coalition
May 28, 2021: Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abliva AB
  • Alimera Sciences Inc
  • Allegro Ophthalmics LLC
  • Astellas Pharma Inc
  • Genentech USA Inc
  • Genzyme Corp

Section 1 - About the Company

  • Stealth BioTherapeutics Corp - Key Facts
  • Stealth BioTherapeutics Corp - Key Employees
  • Stealth BioTherapeutics Corp - Key Employee Biographies
  • Stealth BioTherapeutics Corp - Major Products and Services
  • Stealth BioTherapeutics Corp - History
  • Stealth BioTherapeutics Corp - Company Statement
  • Stealth BioTherapeutics Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis

  • Company Overview
  • Stealth BioTherapeutics Corp - Business Description
  • R&D Overview
  • Stealth BioTherapeutics Corp - Corporate Strategy
  • Stealth BioTherapeutics Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Stealth BioTherapeutics Corp - Strengths
  • Stealth BioTherapeutics Corp - Weaknesses
  • Stealth BioTherapeutics Corp - Opportunities
  • Stealth BioTherapeutics Corp - Threats
  • Stealth BioTherapeutics Corp - Key Competitors

Section 3 - Company Financial Ratios

  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

  • Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Stealth BioTherapeutics Corp, Recent Deals Summary

Section 5 - Company’s Recent Developments

  • Nov 11, 2021: Stealth BioTherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
  • Aug 05, 2021: Stealth BioTherapeutics reports second quarter 2021 financial results and recent business highlights
  • Jul 30, 2021: Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5
  • Jul 07, 2021: Stealth BioTherapeutics joins the rare disease company coalition
  • May 28, 2021: Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference
  • May 18, 2021: Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights
  • May 11, 2021: Stealth BioTherapeutics to Report First Quarter Financial Results on Tuesday, May 18, 2021
  • Apr 06, 2021: Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
  • Mar 31, 2021: Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021
  • Mar 16, 2021: Stealth BioTherapeutics Announces Promotion of Marty Redmon to Chief Research & Development Officer

Section 6 - Appendix

  • Methodology
  • Ratio Definitions
  • About the Publisher

List of Tables

  • Stealth BioTherapeutics Corp, Key Facts
  • Stealth BioTherapeutics Corp, Key Employees
  • Stealth BioTherapeutics Corp, Key Employee Biographies
  • Stealth BioTherapeutics Corp, Major Products and Services
  • Stealth BioTherapeutics Corp, History
  • Stealth BioTherapeutics Corp, Subsidiaries
  • Stealth BioTherapeutics Corp, Key Competitors
  • Stealth BioTherapeutics Corp, Ratios based on current share price
  • Stealth BioTherapeutics Corp, Annual Ratios
  • Stealth BioTherapeutics Corp, Interim Ratios
  • Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Stealth BioTherapeutics Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures

  • Stealth BioTherapeutics Corp, Performance Chart (2016 - 2020)
  • Stealth BioTherapeutics Corp, Ratio Charts
  • Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Regeneron Pharmaceuticals Inc
  • IVERIC bio Inc
  • Ionis Pharmaceuticals Inc
  • Hemera Biosciences Inc
  • Genzyme Corp
  • Genentech USA Inc
  • BioElectron Technology Corp
  • Astellas Pharma Inc
  • Apellis Pharmaceuticals Inc
  • Allegro Ophthalmics LLC
  • Alimera Sciences Inc
  • Abliva AB
Note: Product cover images may vary from those shown